3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents

K. Poojita; Fajeelath Fathima; Rajdeep Ray; Lalit Kumar; Ruchi Verma

doi:10.52711/0974-360X.2021.01026

3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents

K. Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma

Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal
Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal

Research output: Contribution to journal › Article › peer-review

Abstract

Tuberculosis disease is world’s biggest threat to health with a high mortality rate. There has been a steady surge in the frequency of MDR-TB and XDR-TB. Hence, it is imperative to encourage the research and development of novel drugs to counteract the infection. Decaprenylphosphoryl-ß-D-ribose-2'α-epimerase 1 (DprE1) is a valuable enzyme which is responsible for the stability and virulence of the infection causing bacteria (Mycobacterium tuberculosis) thereby making it a perfect target for drugs anti TB activity. This study represent atom based 3D QSAR model consisting the derivatives of DprE1 inhibitors and provides guidance and insight to develop and identify new novel molecule which have good therapeutic efficiency as Anti TB drugs.

Original language	English
Pages (from-to)	5903-5910
Number of pages	8
Journal	Research Journal of Pharmacy and Technology
Volume	14
Issue number	11
DOIs	https://doi.org/10.52711/0974-360X.2021.01026
Publication status	Published - 11-2021

All Science Journal Classification (ASJC) codes

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.52711/0974-360X.2021.01026

Cite this

@article{1c7dac73f2624a038bbf24dcf3fda11a,

title = "3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents",

abstract = "Tuberculosis disease is world{\textquoteright}s biggest threat to health with a high mortality rate. There has been a steady surge in the frequency of MDR-TB and XDR-TB. Hence, it is imperative to encourage the research and development of novel drugs to counteract the infection. Decaprenylphosphoryl-{\ss}-D-ribose-2'α-epimerase 1 (DprE1) is a valuable enzyme which is responsible for the stability and virulence of the infection causing bacteria (Mycobacterium tuberculosis) thereby making it a perfect target for drugs anti TB activity. This study represent atom based 3D QSAR model consisting the derivatives of DprE1 inhibitors and provides guidance and insight to develop and identify new novel molecule which have good therapeutic efficiency as Anti TB drugs.",

author = "K. Poojita and Fajeelath Fathima and Rajdeep Ray and Lalit Kumar and Ruchi Verma",

year = "2021",

month = nov,

doi = "10.52711/0974-360X.2021.01026",

language = "English",

volume = "14",

pages = "5903--5910",

journal = "Research Journal of Pharmacy and Technology",

issn = "0974-3618",

publisher = "A and V Publication",

number = "11",

}

TY - JOUR

T1 - 3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents

AU - Poojita, K.

AU - Fathima, Fajeelath

AU - Ray, Rajdeep

AU - Kumar, Lalit

AU - Verma, Ruchi

PY - 2021/11

Y1 - 2021/11

N2 - Tuberculosis disease is world’s biggest threat to health with a high mortality rate. There has been a steady surge in the frequency of MDR-TB and XDR-TB. Hence, it is imperative to encourage the research and development of novel drugs to counteract the infection. Decaprenylphosphoryl-ß-D-ribose-2'α-epimerase 1 (DprE1) is a valuable enzyme which is responsible for the stability and virulence of the infection causing bacteria (Mycobacterium tuberculosis) thereby making it a perfect target for drugs anti TB activity. This study represent atom based 3D QSAR model consisting the derivatives of DprE1 inhibitors and provides guidance and insight to develop and identify new novel molecule which have good therapeutic efficiency as Anti TB drugs.

AB - Tuberculosis disease is world’s biggest threat to health with a high mortality rate. There has been a steady surge in the frequency of MDR-TB and XDR-TB. Hence, it is imperative to encourage the research and development of novel drugs to counteract the infection. Decaprenylphosphoryl-ß-D-ribose-2'α-epimerase 1 (DprE1) is a valuable enzyme which is responsible for the stability and virulence of the infection causing bacteria (Mycobacterium tuberculosis) thereby making it a perfect target for drugs anti TB activity. This study represent atom based 3D QSAR model consisting the derivatives of DprE1 inhibitors and provides guidance and insight to develop and identify new novel molecule which have good therapeutic efficiency as Anti TB drugs.

UR - http://www.scopus.com/inward/record.url?scp=85122163133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122163133&partnerID=8YFLogxK

U2 - 10.52711/0974-360X.2021.01026

DO - 10.52711/0974-360X.2021.01026

M3 - Article

AN - SCOPUS:85122163133

SN - 0974-3618

VL - 14

SP - 5903

EP - 5910

JO - Research Journal of Pharmacy and Technology

JF - Research Journal of Pharmacy and Technology

IS - 11

ER -

3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this